Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes

• Main Authors: Ma D., Wei H., Lu J., Huang D., Liu Z., Loh L.J., Islam O., Liew R., Shim W., Cook S.A.
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: BioMed Central Ltd. 2019
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/150849
• Institution: National University of Singapore

10.1186/s13287-015-0027-z